Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients

Herpes simplex virus (HSV) and cytomegalovirus (CMV) are DNA viruses that are common among humans. Severely immunocompromised patients are at increased risk of developing HSV or CMV disease due to a weakened immune system. Antiviral therapy can be challenging because these drugs have a narrow therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Huntjens, Daan W., Dijkstra, Jacob A., Verwiel, Lisanne N., Slijkhuis, Mirjam, Elbers, Paul, Welkers, Matthijs R. A., Veldkamp, Agnes I., Kuijvenhoven, Marianne A., de Leeuw, David C., Abdullah-Koolmees, Heshu, Kuipers, Maria T., Bartelink, Imke H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863155/
https://www.ncbi.nlm.nih.gov/pubmed/36678792
http://dx.doi.org/10.3390/pharmaceutics15010163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863155/
https://www.ncbi.nlm.nih.gov/pubmed/36678792
http://dx.doi.org/10.3390/pharmaceutics15010163

Ejemplares similares